Our findings reveal the contribution of SPRY4 to hAMSC adipogenesis, and further identification of the cell type-specific signalling pathways in hAMSC adipogenesis, will help to expand the treatment options for combating obesity and the related health complications. The gene discussed is SPRY4; the disease is obesity due to melanocortin 4 receptor deficiency.